<?xml version="1.0" encoding="UTF-8"?>
<p>Virus neutralization (VN) tests, plaque reduction (PR) assays and indirect enzyme-linked immunosorbent assays (iELISAs) are the main platforms used to detect antibodies against CeMV. The iELISA allows the detection of antibodies directed against the N, P, F and H CeMV proteins [
 <xref rid="B73-viruses-06-05145" ref-type="bibr">73</xref>] whereas only antibodies to the surface glycoproteins (H and F) are detected by the VN and PR assays [
 <xref rid="B16-viruses-06-05145" ref-type="bibr">16</xref>]. Morbilliviruses are antigenically closely related and may cross-neutralize one another. However, serum raised against one morbillivirus will neutralize the homologous virus at a higher titer than it will heterologous morbilliviruses [
 <xref rid="B63-viruses-06-05145" ref-type="bibr">63</xref>,
 <xref rid="B74-viruses-06-05145" ref-type="bibr">74</xref>]. Thus, when working with cetaceans it is very important to use CeMV strains in the serological tests to avoid false negatives. 
</p>
